Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair

Loebel C., Burdick JA.

Narrative Review on Immune Modulation, published in Cell Stem Cell (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cell Stem Cell (2018)
Reported sample size
—
Source database
Europe PMC
PMID
29429944
PMCID
PMC5834383
DOI
10.1016/j.stem.2018.01.014
Citations
105

Abstract (original English)

Stem cells and tissue-derived stromal cells stimulate the repair of degenerated and injured tissues, motivating a growing number of cell-based interventions in the musculoskeletal field. Recent investigations have indicated that these cells are critical for their trophic and immunomodulatory role in controlling endogenous cells. This Review presents recent clinical advances where stem cells and stromal cells have been used to stimulate musculoskeletal tissue repair, including delivery strategies to improve cell viability and retention. Emerging bioengineering strategies are highlighted, particularly toward the development of biomaterials for capturing aspects of the native tissue environment, altering the healing niche, and recruiting endogenous cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Musculoskeletal SystemStromal CellsStem CellsAnimalsHumansStem Cell TransplantationTissue EngineeringRegeneration

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research